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Key Points:  
1) This study examines community dispensed prescriptions from a 
representative sample of an entire geographical population, and reports a 
significant increase in psychoactive prescribing comparing 1995 to 2010. 
2) The variation of different individual drug classes and combinations of 
medications over this period can be explained by the availability of new 
psychoactive drugs, safety concerns, and economic factors. 
3) Reviewing changes in psychoactive prescribing practice in the community 
over time can help clinicians reflect upon the current and previous exposure 
to psychoactive medications that older people have had, and provide a 
platform to assess why these changes have arisen.  
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Abstract 
Objective: The objective of the study was to review prescribing of psychoactive 
medications (drugs affecting the central nervous system) for older residents within 
Tayside.  
 
Methods: The analysis used community-prescribing data in 1995 and 2010 for all 
older residents in Tayside. For each psychoactive drug class, the name of the most 
recently prescribed drug and date prescribed were extracted. The relative risk (RR) 
and 95% confidence intervals for patients receiving psychoactive medication in 2010 
was compared to patients in 1995. Psychoactive prescribing was analyzed by year, 
age, gender, and deprivation classification. The chi-squared test was used to 
calculate statistical significance.  
 
Results: Total psychoactive prescribing in the over 65s has increased comparing 
1995 to 2010. Antidepressant [RR=2.5 (2.41-2.59) p-value=<0.0001], and opioid 
analgesia [RR=1.21 (1.19-1.24) p-value=<0.0001] prescriptions increased between 
1995 and 2010. Hypnotics/anxiolytic [RR=0.69 (0.66-0.71) p-value=<0.0001], and 
antipsychotic [RR=0.83 (0.77-0.88) p-value=<0.0001] prescriptions decreased 
between 1995 and 2010. An increase in psychoactive prescribing is particularly 
marked in lower socioeconomic quintiles. Patients in quintile 1 (least affluent) had 
RR=1.25 (1.20-1.29) [p-value=<0.0001] of being prescribed one to two psychoactive 
medications, and RR=1.81 (1.56-2.10) [p-value=<0.0001] of being prescribed three or 
more psychoactive medications in 2010 compared to 1995. The RRs for quintile 5 
(most affluent) were RR=1.14 (1.1-1.19) [p-value=<0.0001] and RR=1.2 (1.01-1.42) 
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[p-value=<0.0001] for one to two and three or more medications respectively. 
 
Conclusion: Psychoactive medication prescribing has increased comparing 1995 to 
2010, with increases disproportionately affecting patients in lower socioeconomic 
groups. The availability of new psychoactive drugs, safety concerns, and economic 
factors may explain these increases. 
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Introduction 
We are living in an increasingly ageing society, with a recent report by the United 
Nations stating that in 2050 for every one child, there will be four people aged 80 
years or over (United Nations, 2009). The potential implications of an ageing society 
are wide ranging, with healthcare services being particularly affected. Older people 
(>65 years) may have different healthcare needs, are more likely to have co-morbid 
diseases, are commonly prescribed multiple drugs, and are at a greater risk of both 
adverse drug reactions (ADRs) and ADR related hospital admissions (Mizokami et al 
2012; Ruiter et al, 2012). Importantly, older people are often prescribed medications 
with psychoactive properties, agents that affect mood, perception, cognition, 
behavior or consciousness as a result of changes in the functioning of the central 
nervous system (Thronson & Pagalilauan, 2014). These medications are known to 
have a considerable side-effect profile in older patients (Guthrie et al, 2010). The 
properties of psychoactive medications may be intentional to manage particular 
patient symptoms or a side-effect of a medication prescribed for another reason. 
Research assessing psychoactive drug prescribing in older patients showed that 
patients over 65 are not uncommonly prescribed antidepressants (10.8%), 
hypnotic/anxiolytics (7.5%) and antipsychotic medications (1%) (Guthrie et al, 2010). 
Furthermore, it is common for patients to be prescribed more than one agent with 
psychoactive properties (Guthrie et al, 2010; Hughes et al, 2012). However, studies 
of temporal changes in psychoactive prescribing are limited in number and have 
tended to focus only on individual drug classes.  
 
Information gained from assessing trends in the prescribing of a single psychoactive 
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drug is valuable. However, assessing changes in multiple psychoactive drug groups 
over a period of time will provide more information about how these drugs as a 
whole are utilized by healthcare professionals to treat conditions, how broader 
changes in clinical practice may influence the prescription rates of certain agents and 
how different groups of patients are affected by these wider changes in clinical 
practice. Furthermore, reviewing the prescriptions of multiple psychoactive drugs 
will assist further research into the potential pharmacological burden that patients 
prescribed several psychoactive drugs may experience. Indeed, psychoactive drug 
burden is becoming an important area in clinical research, for clinical areas such as 
falls (Pratt et al, 2014) and cognition (Narayan et al, 2013).  
 
This study reports a descriptive epidemiology study of dispensed psychoactive 
medications in a representative population of older people resident in the Tayside 
region of Scotland, United Kingdom. The aim of the study was to review prescribing 
trends of psychoactive medications for older patients within Tayside in 1995 and 
2010 providing information both on patients taking single psychoactive medications 
and patients on multiple psychoactive agents. In addition to reviewing the overall 
changes in psychoactive prescribing, we wished to compare how different 
demographic variables impacted the overall changes in prescribing between 1995 
and 2010.  
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Methods 
The analysis uses community dispensed prescribing data for all residents of the 
Tayside region of Scotland held by the University of Dundee Health Informatics 
Centre (HIC). Data were extracted from 315 General Practices participating in the 
Scottish Program for Improving Clinical Effectiveness – Primary Care (SPICE-PC), a 
program that covers 31% of all Scottish general practices (Elder et al, 2007).  
 
Data were fully anonymised by HIC, and all analysis was compliant with HIC Standard 
Operating Procedures that have been approved by the NHS East of Scotland 
Research Ethics Service and the NHS Tayside Caldicott Guardian. Ethical review of 
this specific project was therefore not required. Analysis was carried out in SPSS 
v18.0 (SPSS Inc, 2009). Data were extracted for people aged 65 and over on two 
dates – 31st March 1995 and 31st March 2010. After reviewing the datasets, 165 
duplicate records were removed (ie- identical patient records appearing twice in 
either the 1995 or 2010 dataset). Demographic data extracted included age, gender 
and postcode- assigned deprivation score (Scottish Index of Multiple Deprivation 
(SIMD) Quintiles), and was linked to dispensed prescribing data. The SIMD is based 
upon information from the major population surveys in Scotland - the Scottish 
Household Survey, the Scottish Health Survey, the Scottish Crime and Justice Survey 
and the Annual Population Survey (Scottish Index of Multiple Deprivation, 2012). It 
provides a method of comparing the differences between the most deprived areas 
and the rest of the population in Scotland, in areas such as the labor market; 
education; health; crime; transport; and perceptions of neighborhood and local 
public services (Scottish Index of Multiple Deprivation, 2012).  
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For each individual, community dispensed prescriptions for psychoactive drugs were 
extracted. Psychoactive medications were defined after consulting the British 
National Formularly (BNF) published in 2012 (BNF, 2012). Thus, drugs defined as 
psychoactive included hypnotics (defined as drugs in BNF chapter 4.1.1), anxiolytics 
(BNF chapter 4.1.2), drugs used in psychosis (BNF chapter 4.2), antidepressants (BNF 
chapter 4.3), and opioid analgesics (BNF chapter 4.7). All of these drug classes have 
been associated with clinically important side-effects for older people as a direct 
result of their actions on the central nervous system  (Fastbom & Schmidt, 2010; 
Milos et al, 2014; Moore & O’Keeffe, 1999). 
 
For each drug class, the name of the most recently prescribed drug and the date 
prescribed were extracted, and a drug was defined as ‘currently prescribed’ if it had 
been prescribed in the 84 days before the 31st March 1995 or the 31st March 2010. 
Therefore, only drugs dispensed in the last 84 days in both data-sets were deemed a 
current prescription and used in the analysis. The proportion of people aged 65 and 
over prescribed each drug class was calculated for patients in 1995 and patients in 
2010. The eleven combinations of medications using antipsychotics, 
hypnotic/anxiolytics, antidepressants and opioid analgesia were then analyzed. In 
addition, to establish baseline characteristics of total prescribing for each individual 
(i.e. not only psychoactive prescribing), community dispensed prescription for all 
drugs were recorded as a total number (with no information about drug name and 
dose).  
 
The relative risk (RR) and 95% confidence intervals for patients receiving 
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psychoactive medication in 2010 was compared to patients in 1995. A psychoactive 
drug count was calculated by adding up prescribed medications in all of the 
psychoactive drug classes. Hypnotic and anxiolytic medications were able to 
separated in this analysis, giving a psychoactive drug count ranging from 0 to 5. 
Psychoactive prescribing trends were analysed by year, age, gender, and deprivation 
classification. The chi-squared test was used to determine whether observed 
changes were significantly different from chance.  
 
Results 
Patient Characteristics in 1995 and 2010 
There were a total of 67,608 patients aged 65 and over who were registered with a 
Tayside practice in 1995 and 73,465 patients in 2010.  Table 1 summarizes the main 
patient characteristics in the 1995 and 2010 datasets. 
 
There was a considerable increase in the net number of patients over the age of 65 
living in Tayside between 1995 and 2010, with the median age increasing by one 
year to 74. There were additional differences in the gender ratios and deprivation 
quintiles comparing 1995 to 2010. Comparing 1995 and 2010 the number of women 
over 65 decreased by 3.4% relative to the male population [p-value= <0.0001] and 
there was a decrease in the number of patients in the higher three deprivation 
quintiles, leading to over 50% of the population being in the two lower deprivation 
quintiles in 2010 [p-value=<0.0001]. There was also a considerable increase in the 
number of total medications (i.e. all types of medications not just psychoactive 
medications) that patients were prescribed. There was a 24.5% increase in the total 
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number of patients being prescribed five or more drugs, with the number of patients 
being prescribed ten or more medications almost trebling between 1995 and 2010 
[p-value=<0.0001]. Importantly, there was almost a 50% reduction in the proportion 
of patients prescribed no medications [p-value=<0.0001].  
 
Insertion of Table 1.  
 
Prescribing Trends by Age Band and Gender 
Table 2 presents the proportions of patients prescribed any psychoactive 
medications in 1995 and 2010 by age and gender. Patients in all age groups were 
relatively more likely to be prescribed one or more psychoactive agents in 2010 
compared to 1995. At both time points there was a steady increase in the proportion 
of patients that were prescribed a psychoactive medication as they aged, with the 
proportions for all five-age brackets being greater in 2010. 
 
Insertion of Table 2 
 
Women are prescribed more psychoactive medication than men in both 1995 and 
2010, although the overall relative percentage increase in prescribing comparing 
1995 to 2010 was higher in the male group. In 1995 the RR of a female being 
prescribed any psychoactive medication compared to a male was 1.69 [95% CI 1.65-
1.74 p-value=<0.0001] with this decreasing to 1.49 [95% CI 1.49-1.52 p-
value=<0.0001] in 2010. In particular, women were more likely to be prescribed 
three or more psychoactive medications in both 1995 and 2010 compared to men, 
with a RR of 2.97 [95% CI 2.59-3.41 p-value=<0.0001] in 1995 and RR of 2.15 [95% CI 
1.95 – 2.36 p-value=<0.0001] in 2010 . 
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Prescribing Trends by Socioeconomic Status  
Overall there has been an increase in psychoactive medication prescribing across all 
socioeconomic groups between 1995 and 2010. However, changes in psychoactive 
prescribing have not been the same across the socioeconomic spectrum.  
 
Despite all groups seeing an increase in RR of being prescribed psychoactive 
medications, patients in higher socioeconomic groups have seen smaller increases of 
risk of being prescribed psychoactive medications. Patients in quintile 1 (least 
affluent) had a 1.25 [95% CI 1.20-1.29 p-value=<0.0001] RR of being prescribed one 
or two psychoactive medications and a 1.81 [95% CI 1.56 – 2.10 p-value=<0.0001] RR 
of being prescribed 3 or more psychoactive medications in 2010 compared to 1995. 
The RRs for patients in quintile 3 was 1.14 [95% CI 1.09-1.18 p-value=<0.0001] and 
1.61 [95% CI 1.36-1.9 p-value=<0.0001] for being prescribed one or two psychoactive 
medications and three or more psychoactive medications respectively. The RR for 
patients in quintile 5 were 1.14 [95% CI 1.1- 1.19 p-value=<0.0001] and 1.2 [95% CI 
1.01-1.42 p-value=<0.0001] for being prescribed one or two psychoactive 
medications and three or more psychoactive medications respectively.   
 
Trends in Psychoactive Prescribing  
Table 3 notes the prevalence of patients prescribed one or more of the psychoactive 
drugs assessed in this study [antidepressants, drugs used in psychoses, opioid 
analgesia and hypnotics/anxiolytics] in 1995 and 2010. RR ratios, two-tailed p-valued 
and 95% confidence intervals are also noted in the table.  
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The prescription of two medications decreased between 1995 and 2010, 
hypnotic/anxiolytic medications and drugs used for psychoses. Furthermore, the RR 
of being prescribed no psychoactive medications decreased over the same period. 
However, the RR of being prescribed antidepressants and opioid analgesia was 
significantly higher in 2010 compared to 1995. 
 
Eleven combinations of psychoactive medications were then reviewed. The 
prescription of three psychoactive medications combinations decreased comparing 
1995 to 2010: hypnotic/anxiolytic & opioid analgesia, hypnotic/anxiolytic & drugs 
used for psychoses, and drugs used for psychoses & opioid analgesia. The other eight 
combinations increased in frequency in 2010 compared to 1995. Two combinations 
increased considerably, antidepressants & opioid analgesia and hypnotic/anxiolytic 
& opioid analgesia & antidepressants.  
 
 
Insertion of Table 3.  
 
 
Table 4 shows the results of a psychoactive drug count and includes all 5 
psychoactive groups (separating hypnotic and anxiolytic medications). Therefore, 
this drug count ranges from zero (patient is not prescribed any drugs from the five 
CNS active drug classes) to five (patient is prescribed drugs from all of the five CNS 
active drug classes). Patients have an increased RR of being prescribed between one 
and five psychoactive medications in 2010 compared to 1995.  
 
 
Insertion of Table 4 
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Discussion 
Key Findings 
Between 1995 and 2010, there was an increase in the number of people living in 
Tayside (Scotland) over the age of 65, reflecting the change in the United Kingdom as 
a whole (Rutherford, 2012). In addition, there was a significant increase in social 
deprivation according to SMID social deprivation scoring quintiles.  
 
The study has reported that people over 65 in Tayside, were more likely to receive 
medications of all forms in 2010 compared to 1995. Indeed, between 1995 and 2010 
the total number of all drugs dispensed increased from a median of 3 in 1995 to 5 in 
2010, alongside a statistically significant 23.6% increase in older people taking 5 or 
more medications. Importantly, this study reports that psychoactive medication 
prescribing has increased in 2010 compared to 1995. However, these increases have 
varied depending upon psychoactive drug class, with prescriptions of antidepressant 
and opioid analgesia increasing and prescriptions of antipsychotics and 
hypnotic/anxiolytics reducing. Patients are also more likely to be prescribed multiple 
psychoactive medications in 2010 compared to 1995. Furthermore, the relative 
increases in psychoactive prescribing in 1995 compared to 2010 have been 
significantly greater in lower socioeconomic groups. 
 
The prescription of psychoactive drugs to patients over 65 years old has recently 
become an area of intense interest both medically and politically (Banerjee, 2009). 
Clearly, prescribing psychoactive medications to this patient group is often clinically 
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appropriate and safe, but the risks that these drugs may pose to older people are 
increasingly recognized. One recent study reported that despite increasing evidence 
of adverse outcomes, the proportion of older people prescribed anticholinergic 
medications and the proportion with a high anticholinergic exposure has increased 
between 1995 and 2010 (Sumakadas et al, 2013). In 2009 a report reviewing 
antipsychotic use in dementia patients estimated that current antipsychotic 
prescribing patterns were likely to cause over 1,600 cerebrovascular events and up 
to 1,800 avoidable patient deaths (Banerjee, 2009). Numerous other studies have 
linked psychoactive medications to adverse outcomes including reduced cognition, 
reduced mobility and adverse drug reactions (Banerjee, 2009; Boudreau et al, 2009; 
Gray et al, 2002; Guthrie et al, 2011; Lowry et al, 2011; Sumakadas et al, 2013).  
 
Assessing changes in psychoactive prescribing practice in the community over time 
can help clinicians reflect upon the current and previous exposure to psychoactive 
medications that older people have had, and provide a platform to assess why these 
changes have arisen. Such work can help direct efforts to develop and improve 
current clinical practice. A strength of this particular study is that it examines 
community dispensed use for a representative sample of an entire geographical 
population (Elder et al, 2007; Sumakadas et al, 2013).  
 
Prescribing Trends by Age Band and Gender 
This study reports that the total number of all drugs dispensed increased when 
comparing 2010 prescriptions to 1995 prescriptions. In relation to psychoactive 
medications there was an increase in RR of receiving one or more psychoactive 
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medications for all five age bands between 1995 and 2010.  
 
As patients age they are more likely to be prescribed medications of all forms 
(Mizokami et al, 2012; Ruiter et al, 2012). This has become more pronounced over 
the last 15 years due to new medications in conditions commonly affecting older 
people, such as cardiovascular disease, osteoporosis and diabetes mellitus (Wise, 
2013). Recently, there has been a focus upon promoting rational prescribing and 
reviewing repeat prescriptions of older people because of the increase in 
polypharmacy (The Model of Care Polypharmacy Working Group, 2012; O’Mahony et 
al, 2010; Wise, 2013). Initiatives that aim to optimize prescribing for older people 
through service developments within primary care (The Model of Care Polypharmacy 
Working Group, 2012), are particularly important as it has been reported that 
physicians can feel that solutions to inappropriate prescribing of medication, in 
particular psychoactive prescribing, is beyond the scope of the individual physician 
(Damestoy, Collin & Lalande, 1999). In the past, successful approaches to optimizing 
prescribing for older people have usually been either educational or administrative, 
and a combination of these approaches is recommended (Mort & Aparasu, 2002). 
For example, in America the Omnibus Budget Reconciliation Act of 1987 served as an 
impetus for clinical review and changed practice style for prescribing in nursing 
homes (Lantz, Giambanco & Buchalter, 1996) and was noted to reduce antipsychotic 
prescribing in nursing homes by linking Medicare reimbursement to appropriate 
prescribing (Gurvich & Cunningham, 2000; Lantz, Giambanco & Buchalter, 1996; 
Mort & Aparasu, 2002). In the UK, linking prescribing reviews to the Quality 
Outcomes Framework (QOF) which awards family doctors points based upon their 
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management of patients, may be able to achieve similar results by allowing primary 
care physicians to be paid for reviewing older patients prescriptions and making 
appropriate adjustments. In the future, making exception reporting easier (ie: 
allowing a doctor to receive a QOF point despite not prescribing a statin in a frail and 
multi-morbid older man with high cholesterol) may allow family practitioners to 
provide rational prescribing to older people both in terms of psychoactive 
prescribing and more broadly. 
 
In both years, 1995 and 2010, women were more likely to prescribed psychoactive 
medications compared to men. This may relate to the fact that women are more 
likely to have been treated for a mental health problem than men (29% compared to 
17%) (National Statistics, 2003). It is postulated that this is because women report 
symptoms of the most common mental health disorders more readily to primary 
care physicians (Gurvich & Cunningham, 2000; National Institute for Clinical 
Excellence, 2009). Furthermore, men are more likely to develop conditions where 
psychoactive prescribing is not generally indicated long-term, such as alcohol and 
substance misuse (National Statistics, 2003). Psychoactive prescribing increased for 
both genders between 1995 and 2010, which may relate to the management of 
depression and anxiety disorders with the newer antidepressants not available in 
1995, alongside the increased use of opioid prescribing for pain syndromes.  
 
Prescribing Trends by Socioeconomic Status 
This study reports that older patients in lower economic quintiles were more likely 
to be prescribed psychoactive medications in both 1995 and 2010. In 2010 over 50% 
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of the population were placed in the two lower deprivation quintiles following 
complex social and economic changes to the population. Based upon analysis of 
previous economic experiences, a nation’s economic health is intricately linked with 
its mental and physical health (Cooper, 2011; The Black Report, 1980). Financial 
crises with their associated rising unemployment, social inequality and social 
insecurity have been linked with higher suicide rates and less clear relationships with 
increases in prevalence of psychiatric illnesses, alcohol-related disorders and drug 
use (Cooper, 2011). Indeed, English data collected between 2008 - 2011 following 
the recession, reported increases of more than 40% in the number of people seeking 
treatment for mental health disorders, and an increase in the number of people 
diagnosed with depression by 11.5% (SSentif Online, 2013). Therefore, higher levels 
of social deprivation in 2010 may partially explain higher rates of psychoactive 
prescribing in 2010 compared to 1995. This increase may reflect higher rates of both 
mental and physical ill health in patients in the lower economic quintiles. 
 
Trends in Psychoactive Prescribing 
The prescription of hypnotic/anxiolytic medications and drugs used for psychoses 
decreased between 1995 and 2010. The authors postulate that the reduction in 
drugs used for psychoses was mainly due to the large-scale reduction in the 
prescription of thioridazine, rather than a reduction of all agents in this drug group. 
Thioridazine was an atypical antipsychotic that was used in the 1990s as an anxiolytic 
and sedative (at lower doses). The drug was withdrawn from the market worldwide 
in 2005 following concerns about high rates of cardiotoxicity and of fatal 
dysrhythmias when compared to other antipsychotics (Purhonen et al, 2012; Reilly 
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et al, 2000). Indeed in contrast to our finding of a reduction in antipsychotic 
prescribing, there have been numerous concerns about the over-use of antipsychotic 
medications in older patients with dementia to manage behavioral and psychological 
symptoms of dementia, despite the literature being skeptical of their efficacy 
(Banerjee, 2009; Declercq et al, 2013; Gustafsson et al, 2013; Guthrie et al, 2010). 
Furthermore, a study looking at the prescribing pattern of psychoactive drugs in 
nursing home residents with dementia, concluded that of all psychoactive drugs 
antipsychotics were the most commonly prescribed drug class (Wetzels et al, 2011).   
 
The significant reduction in the prescription of hypnotic and anxiolytic agents 
appears to reflect concerns about drug dependence, tolerance and efficacy 
alongside the occurrence of significant side-effects in older people. Indeed, there is 
clear evidence that benzodiazepines and other sedative–hypnotic medications 
significantly increase the risk of falls and hip fractures in older people (American 
Geriatric Society Choosing Wisely Working Group, 2013). Furthermore, these 
medications may lead to cognitive problems in the over 65s, with a meta-analysis of 
randomised controlled trials enrolling older adults reporting that memory problems, 
disorientation, and confusion are more common with benzodiazepines and newer 
non-benzodiazepine hypnotics than placebo (Glass et al, 2005). Finally, there is 
evidence that newer antidepressants may be able to manage patients with anxiety 
more safely (Lieberman, 2003) and the non-drug options for managing anxiety 
(National Institute for Clinical Excellence, 2009) and insomnia (Lamberg, 2008) now 
have good evidence basis.  
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The prescription of antidepressants and opioid analgesia increased between 1995 
and 2010. Antidepressant medications have evolved since 1995 with dual-acting 
(norepinephrine and serotonin) antidepressants such as venlafaxine, duloxetine and 
mirtazapine now available (National Institute for Clinical Excellence, 2009). In 
addition, over the last decade there has been research looking into how these agents 
may be used to treat other conditions including anxiety and neuropathic pain 
(National Institute for Clinical Excellence, 2009). Finally, compared to 1995 the 
majority of patients with depression have their condition and prescriptions handled 
entirely in the community by primary care physicians (National Institute for Clinical 
Excellence, 2009; van Weel, van Weel-Baumgarten & van Rijswijk, 2009).  
 
The increase in opioid analgesia prescriptions appear to relate primarily to efforts 
over the last decade to improve the management of pain in older patients, which 
has historically been under-treated (Hughes, 2012; National Institute for Clinical 
Excellence, 2012). The National Institute of Clinical Excellence (NICE) have reported 
that strong opioids are the principal treatments for pain related to advanced and 
progressive disease, and their use has increased significantly in the primary care 
setting in recent years (National Institute for Clinical Excellence, 2012). Indeed, there 
have been numerous guidelines that have reviewed the use of opioid analgesia in 
older people (Canadian Guideline for Safe and Effective Use of Opioids for Chronic 
Non-Cancer Pain, 2012; National Institute for Clinical Excellence, 2012). These 
guidelines have suggested that these medications are both effective and safe in 
older people when prescribing cautions are implemented by prescribers (e.g. 
starting initial titration at no more than 50% of the suggested initial dose for adults 
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and lengthening the time interval between dose increases). However, in the US 
there does remain concern that the prescription of opioid analgesia in non-cancer 
patients may be excessive and other therapeutic options under-used (Daubresse et 
al, 2013). 
 
The changes in drug combinations between 1995 and 2010 appear to reflect changes 
in individual psychoactive medications during this period. 
 
Limitations 
This research paper has several limitations that should be considered each in turn. 
Firstly, this paper reports a patient being prescribed a psychoactive medication 
based upon community prescription data at two specific time-points, once in 1995 
and once in 2010. Therefore, the data obtained does not allow us to fully ascertain 
the changes in prescribing practice that have arisen over this period of time, merely 
to compare these two time points. However, such work can be used to provide a 
platform for a discussion in relation to psychoactive prescribing. Secondly, due to the 
nature of the dataset, we were unable to analyze high-risk patient groups in relation 
to psychoactive prescribing, such as those residing in nursing homes, care homes, 
sheltered housing or receiving significant community support. This will be the focus 
of future clinical research, as assessing psychoactive prescribing in these groups and 
comparing them to community-dwelling adults is of great importance. Thirdly, no 
information on the dose of the drug or whether this was an acute, delayed or repeat 
prescription was available. Finally, the data only reflects community-prescribing 
practice, and changes in the same period in secondary care are out-with the scope of 
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this report. However, the paper does highlight several potential areas for further 
work such as hospital prescribing practice, focused research on the relationship 
between economic status and psychoactive prescribing, and psychoactive 
prescribing in the oldest old. 
 
Conclusion 
Psychoactive medication prescribing has increased in 2010 compared to 1995, with 
these increases disproportionately affecting patients in lower socioeconomic groups. 
These changes can be explained by the development and changing safety profiles of 
medications, an ageing multimorbid population, a focus upon prescribing in older 
patients and socioeconomic factors. Reviewing changes in prescribing practice in the 
community over time provides a useful platform for discussion.
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Table 1. Description of Patient Characteristics  
1995 Tayside Dataset [n= 67,608] 
 
2010 Dataset [n=73,465] Two-Tailed P-
Value 
Median Age : 73 years  
[IQR- (25)- 69 years; (75)- 80 years] 
 
Median Age : 74 years  
[IQR- (25)- 69 years; (75)- 80 years] 
<0.0001 
 
60.1% Female (n=40632)  
39.9% Male (n=26976) 
 
56.7% Female (n=41655)  
43.3% Male (n=31810) 
 
<0.0001 
<0.0001 
Number of all drugs dispensed in last 84 days 
Median number of dispensed drugs:- 3 drugs  
[IQR- (25)- 0 drugs; (75)- 5 drugs]  
 
23.8% (n=16091) are taking 0 medications 
46.7% (n=31573) are taking 1-4 medications 
29.5% (n=19944) are taking 5+ medications  
5.8% (n=3921) of those taking 5+ medications 
are taking ≥10  
Number of all drugs dispensed in last 84 days 
Median number of dispensed drugs:- 5 drugs  
[IQR- (25)- 2 drugs; (75)- 8 drugs]  
 
12.1% (n=8889) are taking 0 medications 
33.9% (n=24904) are taking 1-4 medications 
54% (n=39671) are taking ≥5 medications  
16.9% (n=12415) of those taking ≥5 
medications are taking ≥10  
 
 
 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
Scottish Deprivation Quintiles* 
Q1 – 17.7% (n=11967) 
Q2 – 17.7% (n=11967) 
Q3 – 17.9% (n=12101) 
Q4 – 29.9% (n=20215) 
Q5 – 16.8% (n=11358) 
Scottish Deprivation Quintiles* 
Q1 – 12.6% (n=9257) 
Q2 – 14.5% (n=10652) 
Q3 – 17.5% (n=12856) 
Q4 – 33.7% (n=24758) 
Q5 – 21.7% (n=15942) 
 
<0.0001 
<0.0001 
0.1021 
<0.0001 
<0.0001 
 
* Scottish Deprivation Quintiles- socioeconomic deprivation based on the Scottish Index of Multiple score for the patients 
postcode of residence. Quintile 1 is most deprived and Quintile 5 is most affluent 
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Table 2. Number of Psychoactive Medications Prescribed in 1995 & 2010   
 
 1995 
% prescribed any 
psychoactive  
2010 
% prescribed any 
psychoactive 
(number) 
RR (95% CI) 2010 
compared to 1995 
Two-Tailed P-
Value 
Men 21.1  (n= 5,695) 27.4   (n= 8,708) 1.3 (1.26 – 1.34) <0.0001 
Women 35.7  (n= 14,524) 40.9   (n= 17,046) 1.14 (1.12 – 1.16) <0.0001 
65-69 years old 23.4  (n= 4,763) 29.9   (n= 6,137) 1.28 (1.23 – 1.32) <0.0001 
70-74 years old 27.3   (n= 4,998) 32.9    (n= 5,941) 1.20 (1.17 – 1.24) <0.0001 
75-79 years old 32.2   (n= 3,896) 36.2    (n= 5,413) 1.12 (1.09 – 1.16) <0.0001 
80-84 years old 37.4   (n= 3,531) 39.6    (n= 4,268) 1.06 (1.03 – 1.1) 0.0009 
≥ 85 years old 40.6   (n= 3,031) 43.6    (n= 3,995) 1.07 (1.04 – 1.11) <0.0001 
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Table 3. Prevalence of psychoactive drug prescribing in people 65 and over in 1995 
and 2010.  
 
 Number of patients 
(%) in the 1995 
cohort.  
n =  67,608 
Number of 
patients (%) in 
2010 cohort. 
n = 73,465 
RR (95% CI) 2010 
compared to 1995 
Two-tailed   P-
Value 
Currently Prescribed     
None of the 4 drug classes 48,553 (71.8) 49,797 (67.8) 0.94 (0.94 - 0.95) <0.0001 
Any Hypnotic/Anxiolytic  8,270 (12.2) 5,956 (8.1) 0.69 (0.66 - 0.71) <0.0001 
Any Antidepressant  3,666 (5.4) 9,938 (13.5) 2.5 (2.41 - 2.59) <0.0001 
Any Drugs used in Psychoses  1,763 (2.6) 1,582 (2.2) 0.83 (0.77 - 0.88) <0.0001 
Any Opioid Analgesia  11,254 (16.6) 14,812 (20.2) 1.21 (1.19 - 1.24) <0.0001 
     
Currently Prescribed Combinations     
Hypnotic/Anxiolytic and 
Antidepressant  
1,264 (1.9) 2,229 (3.0) 1.62 (1.52 - 1.74) <0.0001 
Hypnotic/Anxiolytic and Drugs used in 
Psychoses  
576 (0.9) 544 (0.7) 0.87 (0.77 - 0.98) 0.021 
Hypnotic/Anxiolytic and Opioid 
Analgesia  
2,841 (4.2) 2,286 (3.1) 0.74 (0.70 - 0.78) <0.0001 
Antidepressant and Drugs used in 
Psychoses  
482 (0.7) 734 (0.9) 1.40 (1.25 - 1.57) <0.0001 
Drugs used in Psychoses and Opioid 
Analgesia  
393 (0.6) 407 (0.6) 0.96 (0.84 - 1.1) 0.5206 
Opioid Analgesia and Antidepressant  1,246 (1.8) 4,000 (5.4) 2.95 (2.77 - 3.15) <0.0001 
Hypnotic/Anxiolytic and Drugs used in 
Psychoses and Antidepressant  
184 (0.3) 294 (0.4) 1.47 (1.22 - 1.78) <0.0001 
Hypnotic/Anxiolytic and Drugs used in 
Psychoses and Opioid Analgesia  
143 (0.2) 164 (0.2) 1.06 (0.84 - 1.33) 0.679 
Hypnotic/Anxiolytic and 
Antidepressant and Opioid Analgesia  
508 (0.8) 998 (1.4) 1.81 (1.62 - 2.01) <0.0001 
Antidepressant and Drugs used in 
Psychoses and Opioid Analgesia  
126 (0.2) 216 (0.3) 1.58 (1.26 - 1.98) <0.0001 
All 4 drug classes  57 (<0.1) 92 (0.1) 1.49 (1.06 - 2.1) 0.0226 
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Table 4. Number of Psychoactive Medications Prescribed in 1995 & 2010   
 
                        Number of Psychoactive Medications [Drug Count] 
  0 1 2 3 4 5 
1995 Patient Number 
(%) 
47389 
(70.1) 
14197 
(21.0) 
4662 
(6.9) 
1124 
(1.7) 
218  
(0.3) 
18 
(<0.1) 
2010 Patient Number 
(%) 
47711 
(64.9) 
17217 
(23.4) 
6307 
(8.6) 
1792 
(2.4) 
386  
(0.5) 
52 
(0.1) 
 RR 2010 
compared to 
1995 
  0.93    1.12   1.25   1.47   1.63   2.71 
 95% CI (0.92 - 
0.93) 
(1.09 - 
1.14) 
(1.20 - 
1.29) 
(1.36 - 
1.58) 
(1.38 - 
1.93) 
(1.51 – 
4.88) 
 Two-Tailed P-
Value 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.0004 
  
 
